2m 2m 2m 2m 2m 2m 2m
CBDMD (YCBD)
NYSE
$0.71+$0.008 (+1.13%)
Price as of Jun 03, 2026 7:29 PM EDT- $8.3MMarket Cap
- -27.48%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CBDMD (YCBD)
$0.71+$0.008 (+1.13%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 19.2M -1.50% | 19.5M -19.35% | 24.2M -31.77% | 35.4M -20.41% | |
Cost of Revenue | 7.2M -3.53% | 7.5M -18.43% | 9.2M -29.76% | 13.1M -9.85% | |
Gross Profit | 12.0M -0.23% | 12.0M -19.91% | 15.0M -32.95% | 22.3M -25.51% | |
Sales and Marketing Expense | 4.4M +4.76% | 4.2M -30.00% | 6.0M -58.14% | 14.3M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 765,078 +9.69% | 697,510 -50.05% | 1.4M +57.90% | 884,380 -28.47% | |
Total Operating Expenses | N/A N/A | N/A N/A | N/A N/A | 971,554 -98.04% | |
Operating Profit | -2.2M -34.77% | -3.3M -85.26% | -22.5M -71.27% | -78.3M +298.99% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | -29,507 N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 +100.00% | -29,507 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 34,308 +216.27% | -29,507 N/A | 0 -100.00% | 239,250 +927.00% | |
Income before Taxes | -2.0M -44.84% | -3.7M -83.87% | -22.9M -67.27% | -70.1M +188.53% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 -100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -2.0M -44.84% | -3.7M -83.87% | -22.9M -67.27% | -70.1M +199.57% | |
Net Income from Continuing Operations Applicable to Common | -4.4M -43.21% | -7.7M -71.40% | -26.9M -63.64% | -74.1M +185.50% | |
Basic EPS and Net Income | -1.09 -39.11% | -1.79 -86.56% | -13.32 +974.19% | -1.24 +163.83% | |
Diluted EPS and Net Income | -1.09 -39.11% | -1.79 -86.56% | -13.32 +974.19% | -1.24 +163.83% | |
Basic Weighted Average Shares | 4.0M -6.72% | 4.3M +113.25% | 2.0M -96.62% | 59.8M +8.76% | |
Diluted Weighted Average Shares | 4.0M -6.72% | 4.3M +113.25% | 2.0M -96.62% | 59.8M +8.76% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.3M -7.80% | 2.5M +36.42% | 1.8M -73.25% | 6.7M -74.56% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 2.3M -7.80% | 2.5M +36.42% | 1.8M -73.25% | 6.7M -74.59% | |
Total Current Assets | 6.6M +2.54% | 6.4M -20.83% | 8.1M -49.60% | 16.0M -56.14% | |
Accumulated Depreciation | 2.3M +18.96% | 1.9M +30.57% | 1.5M +38.34% | 1.1M -43.43% | |
Property and Plant and Equipment and Net | 277,377 -38.94% | 454,268 -36.61% | 716,579 -12.96% | 823,310 -67.86% | |
Total Long-Term Assets | 3.9M -7.72% | 4.2M -48.40% | 8.1M -67.21% | 24.8M -71.96% | |
Total Assets | 10.4M -1.53% | 10.6M -34.66% | 16.2M -60.30% | 40.8M -67.34% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 1.2M +46,902.73% | 2,492 -74.07% | 9,609 -83.84% | |
Total Current Liabilities | 3.2M -62.94% | 8.6M +84.53% | 4.7M -11.64% | 5.3M -23.59% | |
Total Long-Term Debt | N/A N/A | 364,000 +4,044,344.44% | 9 -99.99% | 125,491 +15.15% | |
Total Long-Term Liabilities | 0 N/A | 0 -100.00% | 2.5M -38.91% | 4.1M -72.46% | |
Total Liabilities | 3.2M -62.94% | 8.6M +20.30% | 7.2M -23.52% | 9.4M -56.91% | |
Retained Earnings | -179.4M -1.45% | -182.1M +4.42% | -174.4M +18.27% | -147.4M +101.02% | |
Total Stockholders Equity | 7.2M +268.04% | 2.0M -78.26% | 9.0M -71.26% | 31.4M -69.53% | |
Total Shares Outstanding | 8.9M +126.38% | 3.9M +33.05% | 3.0M -95.12% | 60.7M +4.99% | |
Cash Flow | |||||
Cash from Operating Activities | -1.5M +311.68% | -352,792 -91.80% | -4.3M -71.26% | -15.0M +6.20% | |
Capital Expenditures | 184,172 -3.08% | 190,015 -36.14% | 297,549 -56.79% | 688,680 +101.36% | |
Cash from Investing Activities | -184,172 -36.50% | -290,015 -141.29% | 702,451 +202.00% | -688,680 -73.01% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.4M +11.39% | 1.3M +198.09% | -1.3M -67.22% | -4.0M -114.29% | |
Financials Ratio | |||||
Gross Margin | 62.37% +1.29% | 61.57% -0.70% | 62.01% -1.72% | 63.09% -6.41% | |
Operating Margin | -11.27% -33.78% | -17.02% -81.72% | -93.10% -57.89% | -221.07% +401.30% | |
Return on Assets | -19.44% -29.67% | -27.64% -65.67% | -80.50% -4.85% | -84.60% +326.23% | |
Return on Equity | -44.42% -34.01% | -67.31% -40.65% | -113.40% +8.87% | -104.16% +305.88% | |
Revenue Growth | -1.50% -92.26% | -19.35% -39.11% | -31.77% +55.68% | -20.41% -429.13% | |
Current Ratio | 2.05 +176.68% | 0.74 -57.09% | 1.73 -42.96% | 3.03 -42.60% | |
Cash Ratio | 0.71 +148.77% | 0.28 -26.08% | 0.39 -69.72% | 1.27 -66.70% | |
Debt-to-Equity Ratio | N/A N/A | 0.78 +260,566.67% | 0.0003 -93.02% | 0.004 +168.75% | |
Debt-to-Assets Ratio | N/A N/A | 0.15 +72,450.00% | 0.0002 -93.94% | 0.003 +153.85% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow